[
  {
    "ts": null,
    "headline": "Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research",
    "summary": "Beckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully automated Brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test. Access BD-Tau, along with Beckman Coulter Diagnostics' expanding portfolio of neurodegenerative disease RUO assays, is available for use on the groundbreaking DxI 9000 Immunoassay Analyzer and Access 2 Analyzer. This portfolio of assays enables precision medicine research on",
    "url": "https://finnhub.io/api/news?id=8013e288b5a2a9ec26889b9bdcb9c3df3c12e050468f2193d588d8b57d1f91da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757511060,
      "headline": "Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research",
      "id": 136689436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Beckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully automated Brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test. Access BD-Tau, along with Beckman Coulter Diagnostics' expanding portfolio of neurodegenerative disease RUO assays, is available for use on the groundbreaking DxI 9000 Immunoassay Analyzer and Access 2 Analyzer. This portfolio of assays enables precision medicine research on",
      "url": "https://finnhub.io/api/news?id=8013e288b5a2a9ec26889b9bdcb9c3df3c12e050468f2193d588d8b57d1f91da"
    }
  },
  {
    "ts": null,
    "headline": "Danaher (DHR) Valuation: Is the Recent Slide an Opportunity for Long-Term Investors?",
    "summary": "If you have been following Danaher (DHR) lately, you may have noticed that the stock’s performance has come under the microscope. While there is no single headline grabbing investor attention, the shares have been trending lower, prompting some to wonder if this slide is a warning sign or simply a possible opening for value-driven buyers. For shareholders, the current environment raises a familiar question: is this move noise, or does it signal something deeper happening at the company? Over...",
    "url": "https://finnhub.io/api/news?id=ccf1611559de023081f1fd62579bf345b1b2e8374e9568b3a7285f1fa1ee089e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757506241,
      "headline": "Danaher (DHR) Valuation: Is the Recent Slide an Opportunity for Long-Term Investors?",
      "id": 136689437,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "If you have been following Danaher (DHR) lately, you may have noticed that the stock’s performance has come under the microscope. While there is no single headline grabbing investor attention, the shares have been trending lower, prompting some to wonder if this slide is a warning sign or simply a possible opening for value-driven buyers. For shareholders, the current environment raises a familiar question: is this move noise, or does it signal something deeper happening at the company? Over...",
      "url": "https://finnhub.io/api/news?id=ccf1611559de023081f1fd62579bf345b1b2e8374e9568b3a7285f1fa1ee089e"
    }
  }
]